Cystitis treatment with high dose chondroitin sulfate
AssigneeStellar Pharmaceuticals Inc.
InventorsPeter R. Riehl, Sungtack Samuel Hahn
Life of this patent
Estimating the term…
Abstract
Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.
Claims9
A pharmaceutical composition adapted for instillation to the bladder of a patient, the composition comprising chondroitin sulfate in an amount from 250 mgs to 1200 mgs, and an aqueous vehicle in a volume of from 10 mL to 100 mL.
A pharmaceutical composition, in the form of a sterile chondroitin sulfate solution, consisting of 400 mgs of chondroitin sulfate and 20 mL of an aqueous vehicle.
9-16. (canceled)
Dependencies are inferred from the claim text.